Just – Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN 303
9 August 2022
Evotec SE and Alpine Immune Sciences today announced that Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc., expanded a multi-year partnership with Alpine for the development of a commercial process for ALPN-303.